IDEAS home Printed from https://ideas.repec.org/a/sae/medema/v30y2010i3p409-414.html
   My bibliography  Save this article

Life Expectancy in Individuals With Type 2 Diabetes: Implications for Annuities

Author

Listed:
  • Hermione C. Price

    (Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and MetabolismUniversity of Oxford, Oxford, UK, Hermione.Price@dtu.ox.ac.uk)

  • Philip M. Clarke

    (Department of Public Health, Health Economics Research Centre, University of Oxford, Oxford, UK)

  • Alastair M. Gray

    (Department of Public Health, Health Economics Research Centre University of Oxford, Oxford, UK)

  • Rury R. Holman

    (Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK)

Abstract

Background. Insurance companies often offer people with diabetes ‘‘enhanced impaired life annuity’’ at preferential rates, in view of their reduced life expectancy. Objective. To assess the appropriateness of ‘‘enhanced impaired life annuity’’ rates for individuals with type 2 diabetes. Patients. There were 4026 subjects with established type 2 diabetes (but not known cardiovascular or other life-threatening diseases) enrolled into the UK Lipids in Diabetes Study. Measurements. Estimated individual life expectancy using the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model. Results. Subjects were a mean (SD) age of 60.7 (8.6) years, had a blood pressure of 141/83 (17/10) mm Hg, total cholesterol level of 4.5 (0.75) mmol/L, HDL cholesterol level of 1.2 (0.29) mmol/L, with median (interquartile range [IQR]) known diabetes duration of 6 (3—11) years, and HbA 1c of 8.0% (7.2—9.0). Sixty-five percent were male, 91% white, 4% Afro-Caribbean, 5% Indian-Asian, and 15% current smokers. The UKPDS Outcomes Model median (IQR) estimated age at death was 76.6 (73.8—79.5) years compared with 81.6 (79.4—83.2) years, estimated using the UK Government Actuary’s Department data for a general population of the same age and gender structure. The median (IQR) difference was 4.3 (2.8—6.1) years, a remaining life expectancy reduction of almost one quarter. The highest value annuity identified, which commences payments immediately for a 60-year-old man with insulin-treated type 2 diabetes investing 100,000, did not reflect this difference, offering 7.4K per year compared with 7.0K per year if not diabetic. Conclusions. The UK Government Actuary’s Department data overestimate likely age at death in individuals with type 2 diabetes, and at present, ‘‘enhanced impaired life annuity’’ rates do not provide equity for people with type 2 diabetes. Using a diabetes-specific model to estimate life expectancy could provide valuable information to the annuity industry and permit more equitable annuity rates for those with type 2 diabetes.

Suggested Citation

  • Hermione C. Price & Philip M. Clarke & Alastair M. Gray & Rury R. Holman, 2010. "Life Expectancy in Individuals With Type 2 Diabetes: Implications for Annuities," Medical Decision Making, , vol. 30(3), pages 409-414, May.
    • Handle: RePEc:sae:medema:v:30:y:2010:i:3:p:409-414
    DOI: 10.1177/0272989X09349960
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/0272989X09349960
    Download Restriction: no
    File URL: https://libkey.io/10.1177/0272989X09349960?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Chandola, Tarani, 2000. "Social class differences in mortality using the new UK National Statistics Socio-Economic Classification," Social Science & Medicine, Elsevier, vol. 50(5), pages 641-649, March.
    2. Chandola, T., 2000. "Social class differences in mortality using the National Statistics Socio-economic Classification: a reply to Rose and Pevalin," Social Science & Medicine, Elsevier, vol. 51(7), pages 1129-1133, October.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Kahouli, Sondès, 2020. "An economic approach to the study of the relationship between housing hazards and health: The case of residential fuel poverty in France," Energy Economics, Elsevier, vol. 85(C).
    2. Joan Costa-Font, 2013. "Housing-related Well-being in Older People: The Impact of Environmental and Financial Influences," Urban Studies, Urban Studies Journal Limited, vol. 50(4), pages 657-673, March.
    3. John Sessions & Ge Yu & Martin Wall, 2011. "Social Capital and Health: A Longitudinal Analysis from the British Household Panel Survey," Department of Economics Working Papers 6/11, University of Bath, Department of Economics.
    4. Maheswaran, Hendramoorthy & Kupek, Emil & Petrou, Stavros, 2015. "Self-reported health and socio-economic inequalities in England, 1996–2009: Repeated national cross-sectional study," Social Science & Medicine, Elsevier, vol. 136, pages 135-146.
    5. Jane Fielding, 2007. "Environmental Injustice or Just the Lie of the Land: An Investigation of the Socio-Economic Class of those at Risk from Flooding in England and Wales," Sociological Research Online, , vol. 12(4), pages 12-34, August.
    6. Yu, Ge & Sessions, John G. & Fu, Yu & Wall, Martin, 2015. "A multilevel cross-lagged structural equation analysis for reciprocal relationship between social capital and health," Social Science & Medicine, Elsevier, vol. 142(C), pages 1-8.
    7. Gita Mishra & Kylie Ball & Annette Dobson & Julie Byles & Penny Warner-Smith, 2001. "The Measurement of Socio-Economic Status: Investigation of Gender-and Age-Specific Indicators in Australia: National Health Survey 1995," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 56(1), pages 73-89, October.
    8. Angelo d’Errico & Fulvio Ricceri & Silvia Stringhini & Cristian Carmeli & Mika Kivimaki & Mel Bartley & Cathal McCrory & Murielle Bochud & Peter Vollenweider & Rosario Tumino & Marcel Goldberg & Marie, 2017. "Socioeconomic indicators in epidemiologic research: A practical example from the LIFEPATH study," PLOS ONE, Public Library of Science, vol. 12(5), pages 1-32, May.
    9. Peter Adams & Michael D. Hurd & Daniel L. McFadden & Angela Merrill & Tiago Ribeiro, 2004. "Healthy, Wealthy, and Wise? Tests for Direct Causal Paths between Health and Socioeconomic Status," NBER Chapters, in: Perspectives on the Economics of Aging, pages 415-526, National Bureau of Economic Research, Inc.
    10. Hiyoshi, Ayako & Fukuda, Yoshiharu & Shipley, Martin J. & Brunner, Eric J., 2014. "Health inequalities in Japan: The role of material, psychosocial, social relational and behavioural factors," Social Science & Medicine, Elsevier, vol. 104(C), pages 201-209.
    11. Monica Raileanu Szeles, 2016. "Assessing the Effect of Economic Growth on Well-Being in the Eu-27. A Pareto-Optimum Approach," Working Papers of Institute for Economic Forecasting 161002, Institute for Economic Forecasting.
    12. Monica Răileanu Szeles, 2018. "Comparative Examination of Self-Perceived Health and Other Measures of the Quality of Life Across the EU-27," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 137(1), pages 391-411, May.
    13. Muntaner, Carles & Borrell, Carme & Vanroelen, Christophe & Chung, Haejoo & Benach, Joan & Kim, Il Ho & Ng, Edwin, 2010. "Employment relations, social class and health: A review and analysis of conceptual and measurement alternatives," Social Science & Medicine, Elsevier, vol. 71(12), pages 2130-2140, December.
    14. Ariadna Jou & Nuria Mas & Carles Vergara-Alert, 2023. "Housing Wealth, Health and Deaths of Despair," The Journal of Real Estate Finance and Economics, Springer, vol. 66(3), pages 569-602, April.
    15. Vanhoutte, Bram, 2019. "Age takes hold of us by surprise: Conceptualising Vulnerabilities in Ageing as the Timing of Adverse Events - Pre-print," SocArXiv xqjwv, Center for Open Science.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:medema:v:30:y:2010:i:3:p:409-414. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.